Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice
- PMID: 26329580
- DOI: 10.1126/scisignal.aac8321
Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice
Abstract
Double knockout of PTEN and LKB1-genes encoding phosphatase and tensin homolog and liver kinase B1, respectively-leads to the spontaneous development of cancer in mice. PTEN converts phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to phosphatidylinositol (4,5)-bisphosphate (PIP2), whereas LKB1 activates the 5' adenosine monophosphate-activated protein kinase (AMPK). The kinase AKT and the kinase complex mTORC1 may play key roles in carcinogenesis and are components of signaling pathways that also contain PTEN and LKB1. We propose that via activation of AKT and mTORC1, the double knockout of PTEN and LKB1 contributes to distinct cell-specific aspects of tumor development and progression. Whereas mTORC1 promotes cancer initiation and progression through cell growth, survival, and proliferation, independent induction of the immune inhibitory molecule PD-L1 by activated AKT enables the tumors to evade immunosurveillance.
Copyright © 2015, American Association for the Advancement of Science.
Similar articles
-
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.Biochem J. 2008 Jun 1;412(2):211-21. doi: 10.1042/BJ20080557. Biochem J. 2008. PMID: 18387000
-
PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas.Indian J Med Res. 2016 May;143(Supplement):S112-S119. doi: 10.4103/0971-5916.191808. Indian J Med Res. 2016. PMID: 27748285 Free PMC article.
-
Cancer therapy: staying current with AMPK.Biochem J. 2008 Jun 1;412(2):e3-5. doi: 10.1042/BJ20080823. Biochem J. 2008. PMID: 18466113
-
PTEN, more than the AKT pathway.Carcinogenesis. 2007 Jul;28(7):1379-86. doi: 10.1093/carcin/bgm052. Epub 2007 Mar 6. Carcinogenesis. 2007. PMID: 17341655 Review.
-
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25. Leukemia. 2011. PMID: 21436840 Review.
Cited by
-
Phosphorylation of LKB1 by PDK1 Inhibits Cell Proliferation and Organ Growth by Decreased Activation of AMPK.Cells. 2023 Mar 6;12(5):812. doi: 10.3390/cells12050812. Cells. 2023. PMID: 36899949 Free PMC article.
-
MicroRNAs in multiple myeloma and related bone disease.Ann Transl Med. 2015 Dec;3(21):334. doi: 10.3978/j.issn.2305-5839.2015.12.13. Ann Transl Med. 2015. PMID: 26734644 Free PMC article. Review.
-
Immune Checkpoint Ligand PD-L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis.Am J Respir Cell Mol Biol. 2018 Dec;59(6):723-732. doi: 10.1165/rcmb.2018-0123OC. Am J Respir Cell Mol Biol. 2018. PMID: 30095976 Free PMC article.
-
Scutellarein regulates the PTEN/AKT/NFκB signaling pathway to reduce pirarubicin related liver inflammation.Int J Mol Med. 2023 Jul;52(1):55. doi: 10.3892/ijmm.2023.5258. Epub 2023 May 26. Int J Mol Med. 2023. PMID: 37232353 Free PMC article.
-
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.Onco Targets Ther. 2017 Jan 5;10:205-216. doi: 10.2147/OTT.S116178. eCollection 2017. Onco Targets Ther. 2017. PMID: 28115855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials